Engineering high affinity, soluble T cell receptors for the treatment of cancer. (March 2018) - Holt, L.; Liddy, N.; Bossi, G.; Harper, J.; Dukes, J.; Paston, S.; Mahon, T.; Molloy, P.; Sami, M.; Baston, E.; Cameron, B.; Powesland, A.; et al.